. "Malo\u0161kov\u00E1, Gabriela" . . "7-8" . "Zlatohl\u00E1vkov\u00E1, Blanka" . . "Kytnarov\u00E1, Jitka" . "T\u011B\u017Ek\u00E1 nezralost a intrauterinn\u00ED r\u016Fstov\u00E1 retardace (IUGR) jsou rizikov\u00FDmi faktory pro poruchu postnat\u00E1ln\u00ED adaptace a pro vznik \u0159ady chorob v dosp\u011Blosti. Chronick\u00FD stres b\u011Bhem intrauterinn\u00EDho v\u00FDvoje vede k metabolick\u00FDm a endokrinn\u00EDm zm\u011Bn\u00E1m a k urychlen\u00ED zr\u00E1n\u00ED n\u011Bkter\u00FDch org\u00E1nov\u00FDch syst\u00E9m\u016F. Tyto zm\u011Bny mohou b\u00FDt pro d\u00EDt\u011B kr\u00E1tkodobou v\u00FDhodou, ale v dal\u0161\u00EDm v\u00FDvoji se mohou pod\u00EDlet na rozvoji \u0159ady onemocn\u011Bn\u00ED (syndrom respira\u010Dn\u00ED t\u00EDsn\u011B, bronchopulmon\u00E1ln\u00ED dyspl\u00E1zie, nekrotizuj\u00EDc\u00ED enterokolit\u00EDda atd.). Intrauterinn\u00ED metabolick\u00E9 zm\u011Bny mohou b\u00FDt podkladem pro rozvoj n\u011Bkter\u00FDch chorob v dosp\u011Blosti. Vhodn\u00FDm syst\u00E9mem pro monitoraci metabolick\u00FDch zm\u011Bn u t\u011Bchto novorozenc\u016F by mohl b\u00FDt syst\u00E9m IGF-I, IGF-II a jejich vazebn\u00FDch b\u00EDlkovin (IGFBPs)."@cs . . "Intrauterinn\u00ED r\u016Fstov\u00E1 retardace a jej\u00ED vliv na dal\u0161\u00ED v\u00FDvoj extr\u00E9mn\u011B nezral\u00FDch novorozenc\u016F"@cs . "extremely low birth weight infant; intrauterine growth retardation; insulin-like growth factors IGF-I and IGF-II; insuline-like growth factors binding proteins"@en . "Fedorov\u00E1, M\u00E1ria" . "Intrauterine growth retardation and its impact on postnatal development of extremely premature newborns"@en . "4"^^ . . "RIV/00216208:11110/09:4241!RIV10-MZ0-11110___" . "Intrauterinn\u00ED r\u016Fstov\u00E1 retardace a jej\u00ED vliv na dal\u0161\u00ED v\u00FDvoj extr\u00E9mn\u011B nezral\u00FDch novorozenc\u016F"@cs . "Kr\u0161ek, Michal" . "320222" . "[3A4397354C51]" . "\u010Cesko-slovensk\u00E1 pediatrie" . "0069-2328" . "CZ - \u010Cesk\u00E1 republika" . . "Plavka, Richard" . "Severe immaturity and intrauterine growth retardation (IUGR) pose risk factors for inadequate postnatal adaptation. Chronic stress in prenatal period leads to metabolic and endocrine changes and accelerates maturation of several organ systems. These changes might represent short term advantage for infant but in the later development may worsen the development of many diseases (respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis and so on) Intrauterine metabolic changes may represent the basis for metabolic syndrome and cardiovascular morbidity in adulthood. Insulin-like growth factors (IGF-I, IGF-II and their binding proteins (IGFBPs) appear to be suitable monitoring system of metabolic changes in extremely low birth weight infants."@en . "Intrauterinn\u00ED r\u016Fstov\u00E1 retardace a jej\u00ED vliv na dal\u0161\u00ED v\u00FDvoj extr\u00E9mn\u011B nezral\u00FDch novorozenc\u016F" . "6"^^ . . . . "Intrauterinn\u00ED r\u016Fstov\u00E1 retardace a jej\u00ED vliv na dal\u0161\u00ED v\u00FDvoj extr\u00E9mn\u011B nezral\u00FDch novorozenc\u016F" . . . . . . . "Intrauterine growth retardation and its impact on postnatal development of extremely premature newborns"@en . "11110" . "P(NR9374)" . . "6"^^ . "RIV/00216208:11110/09:4241" . . . "64" . "T\u011B\u017Ek\u00E1 nezralost a intrauterinn\u00ED r\u016Fstov\u00E1 retardace (IUGR) jsou rizikov\u00FDmi faktory pro poruchu postnat\u00E1ln\u00ED adaptace a pro vznik \u0159ady chorob v dosp\u011Blosti. Chronick\u00FD stres b\u011Bhem intrauterinn\u00EDho v\u00FDvoje vede k metabolick\u00FDm a endokrinn\u00EDm zm\u011Bn\u00E1m a k urychlen\u00ED zr\u00E1n\u00ED n\u011Bkter\u00FDch org\u00E1nov\u00FDch syst\u00E9m\u016F. Tyto zm\u011Bny mohou b\u00FDt pro d\u00EDt\u011B kr\u00E1tkodobou v\u00FDhodou, ale v dal\u0161\u00EDm v\u00FDvoji se mohou pod\u00EDlet na rozvoji \u0159ady onemocn\u011Bn\u00ED (syndrom respira\u010Dn\u00ED t\u00EDsn\u011B, bronchopulmon\u00E1ln\u00ED dyspl\u00E1zie, nekrotizuj\u00EDc\u00ED enterokolit\u00EDda atd.). Intrauterinn\u00ED metabolick\u00E9 zm\u011Bny mohou b\u00FDt podkladem pro rozvoj n\u011Bkter\u00FDch chorob v dosp\u011Blosti. Vhodn\u00FDm syst\u00E9mem pro monitoraci metabolick\u00FDch zm\u011Bn u t\u011Bchto novorozenc\u016F by mohl b\u00FDt syst\u00E9m IGF-I, IGF-II a jejich vazebn\u00FDch b\u00EDlkovin (IGFBPs)." . .